Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant.

J Clin Invest · 2023 · PMC10178844 · PMID 36951958

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Conversely, the consistent failure (0/7) of subjects treated with CMVpp65-VSTs restricted by allelic variants of HLA B35 to respond was highly significant ( P = <0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.